A

Applied Therapeutics

D
APLT
USD
0.09
(0.9326%)
Market Closed
63,852.00
حجم التداول
-0.829
الربح لكل سهم
-
العائد الربحي
-6.811189
P/E
1,118,602,679.54
حجم السوق
اليوم
0.9326%
1 اسبوع
10.181%
1 شهر
26.494%
6 اشهر
101.865%
12 اشهر
295.935%
بداية السنة
190.746%
كل الوقت
0%

Title:
Applied Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
هل تحتاج مساعدة او لديك استفسار؟